Intravenous Honokiol in Drug-Resistant Cancer: Two Case Reports
Context: Long-term patient survival in cancer is affected by drug resistance. Honokiol (HNK) is a small-molecule polyphenol isolated from the bark and seed cones of Magnolia officinalis . HNK has been shown to enhance the effects of chemotherapy and inhibit drug resistance in preclinical models. HNK...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2020-06-01
|
| Series: | Integrative Cancer Therapies |
| Online Access: | https://doi.org/10.1177/1534735420922615 |